Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2750
Single User License Price INR 192500
Corporate User License Price USD 4500
Corporate User License Price INR 315000
Site License Price USD 3500
Site License Price INR 245000
Request a Quote

Report Title

Global Wound Biologics Market Trends and Drivers, Restraints, and Opportunities 2018-2024

Quote Request for License Type
License Type Price  
Single User License USD 2750
Site License USD 3500
Enterprise Wide License USD 4500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Global Wound Biologics Market Trends and Drivers, Restraints, and Opportunities 2018-2024


Quote Request for License Type
License Type Price  
Single User License USD 2750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Global Wound Biologics Market Trends and Drivers, Restraints, and Opportunities 2018-2024

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Global Wound Biologics Market Trends and Drivers, Restraints, and Opportunities 2018-2024



Executive Summary

Global Wound Biologics Market-Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017-2023
Overview: Wound care products are mainly intended for safeguarding timely wound healing and active control of infection. There are many wound products accessible in the market, from over-the-counter to prescription products. Maximum wound care products are topical and are permitted as medical devices, but a few products such as biologics are scrutinized under strict regulatory guidelines. The wound biologics market is very unified at present, with the US, Europe, and Japan collectively accounting for a significant share of the product sales. The principal variables are the regulatory trails essential for obtaining marketing approval, with the US regulatory necessities being very different when compared to most of the other nations. Furthermore, the standard of care fluctuates significantly between industrialized and emerging countries, making it tougher to conduct sufficiently precise clinical trials in a global setting.
Skin substitutes, growth factors, and enzyme-based products are the major types of biologics in the market. Nearly half of the skin substitute market is dominated by the major players in the market. Organogenesis, Molnlycke, and Smith & Nephew are the major players in this segment.
The growth of the market is driven by an increase in aging population, increasing number of people suffering from diabetes, growing acceptance of innovative technologies for complex wound treatment, and the rising incidence of chronic wounds. However, the complex regulatory process and the high cost of biologic wound care are hampering the market growth.
Market Analysis: The Global Wound Biologics Market is estimated to witness a CAGR of 12.3% during the forecast period 2017-2023. The market is analyzed based on four segments-products, applications, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the global wound biologics market, followed by Europe, Asia Pacific, and Rest of the World. Nearly half of the market is occupied by North America, with the US being the major contributor to the market growth. In the US, Organogenesis and MiMedx hold nearly half of the skin substitutes market. However, Europe is close to North America with many companies developing advanced technology products. In Germany, Organogenesis and Integra Life Science hold a significant share of the skin substitutes market.
Product Analysis: Skin substitutes, growth factors, and enzyme-based products are the types of wound closure biologics in the market. Skin substitutes are the major segment of the market. MiMedx, Organogenesis, and Smith and Nephew are the key players in the skin substitute market. MiMedx increased its market share from 24.9% in 2015 to 31% in 2016 in the advanced skin substitute market.
Application Analysis: The applications of the wound biologics include chronic wound and acute wound. Acute wound comprises traumatic wound and surgical wound. As the ratio of the surgical wound is higher in comparison with other wound types, the acute wound closure was the major shareholder of the market in 2017. However, the chronic wound is increasing the burden of healthcare expenditure globally. This has increased the demand for innovative products for the treatment, which is expected to experience the fastest growth rate during the forecast period.
Key Players: Organogenesis, Smith & Nephew, MiMedx, and Integra Life Science are the key players in the market. The other prominent players in the market include Pinnacle Transplant, Osiris, Molyncke Health Care, Soluble Systems, Applied Biologics, and Skye Medical.
Competitive Analysis: Many players are using various strategies such as new product launches, clinical trials, market initiatives, high expense on R&D, agreements, joint ventures, acquisitions, and others to increase their footprints in this market. In January 2018, Alliqua BioMedical, Inc. entered a definitive agreement with Celularity, Inc. to acquire all the assets and rights of the company's advanced biologic wound care business. This added Biovance Amniotic Membrane Allograft, Interval Human Connective Tissue Matrix, UltraMist Therapy System, and other therapeutic products to Alliqua's portfolio. In January 2016, Human Regenerative Technologies, LLC initiated the building process of its new state-of-the-art amniotic and placental tissue matrix research, development, and processing facility worth USD 12 million in California, US.
Benefits: The report provides complete details about the usage and adoption rate of wound biologics in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player's initiatives. Moreover, the report provides details about the major challenges that are going to impact on market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:

Table of Contents

1 Industry Outlook 8

1.1 Industry Overview 8

1.2 Industry Trends 9

2 Report Outline 10

2.1 Report Scope 10

2.2 Report Summary 10

2.3 Research Methodology 11

2.4 Report Assumptions 12

3 Market Snapshot 13

3.1 Total Addressable Market 13

3.2 Market Definition-Infoholic Research 13

3.3 Segmented Addressable Market 13

3.4 Trends in Wound Care Biologics Market 14

3.5 Related Markets 15

3.5.1 Active Pharmaceutical Ingredients 15

3.5.2 Diabetes Drugs 16

3.5.3 Regenerative Medicine 16

3.5.4 Oncology (Cancer) Drugs 17

4 Market Outlook 18

4.1 Regulatory Outlook 18

4.2 Market Segmentation 19

4.3 Porter 5(Five) Forces 19

4.4 PEST Analysis 20

5 Market Characteristics 21

5.1 Market Dynamics 21

5.1.1 Drivers 22

5.1.1.1 Increasing aging population 22

5.1.1.2 Rising incidence of chronic wounds 22

5.1.1.3 Increasing number of people suffering from diabetes 23

5.1.1.4 Increasing acceptance of innovative technologies for complex wound treatment 23

5.1.2 Opportunities 24

5.1.2.1 Increase in healthcare spending 24

5.1.2.2 Untapped emerging market in developing countries 24

5.1.3 Restraints 24

5.1.3.1 Complex regulatory process 24

5.1.3.2 High cost of biologic wound care 25

5.2 DRO-Impact Analysis 26

5.3 Key Stakeholders 27

6 Types: Market Size and Analysis 28

6.1 Overview 28

6.2 Growth Factors 29

6.3 Skin Substitutes 30

6.4 Enzyme-based Products 33

7 Application: Market Size and Analysis 35

7.1 Overview 35

7.2 Chronic Wound 36

7.3 Acute Wound 36

8 End-users: Market Size and Analysis 37

8.1 Overview 37

8.2 Hospitals & Clinics 37

8.3 Ambulatory Surgical Centers 38

9 Regions: Market Size and Analysis 39

9.1 Overview 39

9.2 North America 40

9.2.1 Overview 40

9.2.2 US 41

9.2.3 Canada 42

9.3 Europe 42

9.3.1 Overview 42

9.3.2 UK 44

9.3.3 Germany 44

9.4 Asia Pacific 44

9.4.1 Overview 44

9.4.2 India 45

9.4.3 China 45

9.5 Rest of the World 46

9.5.1 Overview 46

9.5.2 Middle East & Africa 47

9.5.3 Brazil 47

10 Competitive Landscape 49

11 Vendor Profiles 51

11.1 Smith & Nephew, Inc. 51

11.1.1 Overview 51

11.1.2 Geographic Revenue 54

11.1.3 Business Focus 54

11.1.4 SWOT Analysis 55

11.1.5 Business Strategies 55

11.2 Organogenesis Inc. 56

11.2.1 Overview 56

11.2.2 Business Focus 57

11.2.3 SWOT Analysis 57

11.2.4 Business Strategies 58

11.3 MiMedx 58

11.3.1 Overview 58

11.3.2 Business Focus 59

11.3.3 SWOT Analysis 60

11.3.4 Business Strategies 60

11.4 Integra Life Sciences Corp. 61

11.4.1 Overview 61

11.4.2 Geographic Revenue 63

11.4.3 Business Focus 64

11.4.4 SWOT Analysis 64

11.4.5 Business Strategies 65

12 Companies to Watch For 66

12.1 Pinnacle Transplant Technologies 66

12.1.1 Overview 66

12.2 Osiris Therapeutics, Inc. 66

12.2.1 Overview 66

12.2.2 Highlights 67

12.3 Molnlycke Health Care AB 67

12.3.1 Overview 67

12.4 Soluble Systems, LLC 68

12.4.1 Overview 68

12.4.2 Highlights 68

12.5 Applied Biologics 69

12.5.1 Overview 69

12.6 Skye Biologics 69

12.6.1 Overview 69

Annexure 71

Abbreviations 71

 

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL WOUND CARE BIOLOGICS MARKET 11

CHART 2 GLOBAL WOUND CARE BIOLOGICS MARKET REVENUE, 2017-2024 (USD MILLION) 15

CHART 3 SEGMENTATION OF GLOBAL WOUND CARE BIOLOGICS MARKET 19

CHART 4 PORTER 5 FORCES OF WOUND CARE BIOLOGICS MARKET 19

CHART 5 PEST ANALYSIS OF WOUND CARE BIOLOGICS MARKET 20

CHART 6 MARKET DYNAMICS-DRO ANALYSIS 21

CHART 7 DRO-IMPACT ANALYSIS OF GLOBAL WOUND CARE BIOLOGICS MARKET 26

CHART 8 KEY STAKEHOLDERS 27

CHART 9 WOUND CARE BIOLOGICS MARKET BY TYPES SEGMENTATION, 2017 VS 2024 (USD MILLION) 28

CHART 10 GROWTH FACTORS MARKET REVENUE BY TYPES SEGMENTATION, 2017-2024 (USD MILLION) 30

CHART 11 SKIN SUBSTITUTES MARKET REVENUE, 2017-2024 (USD MILLION) 32

CHART 12 SKIN SUBSTITUTE MARKET BY TYPES, 2017 (% SHARE) 33

CHART 13 SKIN SUBSTITUTES MARKET BY TYPES SEGMENTATION, 2017 VS 2020 VS 2024 (% SHARE) 33

CHART 14 ENZYME-BASED PRODUCTS MARKET REVENUE BY TYPES SEGMENTATION, 2017-2024 (USD MILLION) 34

CHART 15 WOUND CARE BIOLOGICS MARKET BY APPLICATION SEGMENTATION, 2017 (USD MILLION) 35

CHART 16 WOUND CARE BIOLOGICS MARKET BY END-USERS SEGMENTATION, 2017 (USD MILLION) 37

CHART 17 WOUND CARE BIOLOGICS MARKET BY REGIONAL SEGMENTATION, 2017 VS 2024 (%) 39

CHART 18 WOUND CARE BIOLOGICS MARKET REVENUE IN NORTH AMERICA, 2017-2024 (USD MILLION) 41

CHART 19 EUROPE (EU27) HIGHLIGHTS 42

CHART 20 WOUND CARE BIOLOGICS MARKET REVENUE IN EUROPE, 2017-2024 (USD MILLION) 43

CHART 21 WOUND CARE BIOLOGICS MARKET REVENUE IN ASIA PACIFIC, 2017-2024 (USD MILLION) 46

CHART 22 WOUND CARE BIOLOGICS MARKET REVENUE IN REST OF THE WORLD, 2017-2024 (USD MILLION) 47

CHART 23 SMITH & NEPHEW, INC.: OVERVIEW SNAPSHOT 53

CHART 24 SMITH & NEPHEW, INC.: GEOGRAPHIC REVENUE 54

CHART 25 SMITH & NEPHEW, INC.: SWOT ANALYSIS 55

CHART 26 ORGANOGENESIS INC.: SWOT ANALYSIS 57

CHART 27 MIMEDX: OVERVIEW SNAPSHOT 59

CHART 28 MIMEDX: SWOT ANALYSIS 60

CHART 29 INTEGRA LIFE SCIENCES CORP.: OVERVIEW SNAPSHOT 62

CHART 30 INTEGRA LIFE SCIENCES CORP.: BUSINESS UNITS 63

CHART 31 INTEGRA LIFE SCIENCES CORP.: GEOGRAPHIC REVENUE 63

CHART 32 INTEGRA LIFE SCIENCES CORP.: SWOT ANALYSIS 64

 

Tables

TABLE 1 WOUND CARE BIOLOGICS MARKET REVENUE BY PRODUCT TYPES, 2017-2024 (USD MILLION) 29

TABLE 2 PREVALENCE OF DIFFERENT TYPES OF WOUNDS 35

TABLE 3 WOUND CARE BIOLOGICS MARKET REVENUE BY REGIONS, 2017-2024 (USD MILLION) 40

TABLE 4 SKIN SUBSTITUTES: COMPETITIVE PRODUCT COMPARISON 50

TABLE 5 SMITH & NEPHEW, INC.: PRODUCT OFFERINGS 51

TABLE 6 SMITH & NEPHEW, INC.: RECENT DEVELOPMENTS 51

TABLE 7 ORGANOGENESIS INC.: OFFERINGS 56

TABLE 8 ORGANOGENESIS INC.: RECENT DEVELOPMENTS 56

TABLE 9 MIMEDX: PRODUCT OFFERINGS 58

TABLE 10 MIMEDX: RECENT DEVELOPMENTS 58

TABLE 11 INTEGRA LIFE SCIENCES CORP.: OFFERINGS 61

TABLE 12 INTEGRA LIFE SCIENCES CORP.: RECENT DEVELOPMENTS 61

TABLE 13 PINNACLE TRANSPLANT TECHNOLOGIES: OVERVIEW 66

TABLE 14 OSIRIS THERAPEUTICS, INC.: OVERVIEW 66

TABLE 15 MOLNLYCKE HEALTH CARE AB: OVERVIEW 67

TABLE 16 MOLNLYCKE HEALTH CARE AB: RECENT DEVELOPMENTS 67

TABLE 17 SOLUBLE SYSTEMS LLC: OVERVIEW 68

TABLE 18 APPLIED BIOLOGICS: OVERVIEW 69

TABLE 19 SKYE BIOLOGICS: OVERVIEW 70

TABLE 20 SKYE BIOLOGICS: RECENT DEVELOPMENTS 70

Acelity L.P. Inc., BioD LLC, ConvaTec Group plc, Cytori Therapeutics Inc., Intercytex, Macrocure Ltd., Integra LifeSciences, Organogenesis Inc., Smith & Nephew, Molnlycke Health Care, Nuo Therapeutics Inc., Osiris Therapeutics Inc., and Regenerys Ltd.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person